vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and UDR, Inc. (UDR). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $425.8M, roughly 1.9× UDR, Inc.). UDR, Inc. runs the higher net margin — 44.6% vs 0.5%, a 44.0% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 0.9%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs 1.3%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
UDR, Inc. is a leading U.S.-headquartered real estate investment trust specializing in owning, operating, and redeveloping high-quality multifamily residential apartment communities. It operates across major U.S. metropolitan markets, catering to a diverse tenant base including young professionals, families, and middle-to-high income households.
ACHC vs UDR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $829.0M | $425.8M |
| Net Profit | $4.5M | $189.8M |
| Gross Margin | — | — |
| Operating Margin | — | 54.0% |
| Net Margin | 0.5% | 44.6% |
| Revenue YoY | 7.5% | 0.9% |
| Net Profit YoY | -50.8% | 147.2% |
| EPS (diluted) | $0.05 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $425.8M | ||
| Q4 25 | $821.5M | $433.1M | ||
| Q3 25 | $851.6M | $431.9M | ||
| Q2 25 | $869.2M | $425.4M | ||
| Q1 25 | $770.5M | $421.9M | ||
| Q4 24 | $774.2M | $422.7M | ||
| Q3 24 | $815.6M | $420.2M | ||
| Q2 24 | $796.0M | $415.3M |
| Q1 26 | $4.5M | $189.8M | ||
| Q4 25 | $-1.2B | $222.9M | ||
| Q3 25 | $36.2M | $40.4M | ||
| Q2 25 | $30.1M | $37.7M | ||
| Q1 25 | $8.4M | $76.7M | ||
| Q4 24 | $32.6M | $-5.0M | ||
| Q3 24 | $68.1M | $22.6M | ||
| Q2 24 | $78.5M | $28.9M |
| Q1 26 | — | 54.0% | ||
| Q4 25 | -142.4% | 64.1% | ||
| Q3 25 | 4.7% | 17.7% | ||
| Q2 25 | 5.8% | 18.2% | ||
| Q1 25 | 1.7% | 29.0% | ||
| Q4 24 | 4.9% | 15.7% | ||
| Q3 24 | 12.1% | 16.6% | ||
| Q2 24 | 13.4% | 16.5% |
| Q1 26 | 0.5% | 44.6% | ||
| Q4 25 | -143.3% | 51.5% | ||
| Q3 25 | 4.3% | 9.4% | ||
| Q2 25 | 3.5% | 8.9% | ||
| Q1 25 | 1.1% | 18.2% | ||
| Q4 24 | 4.2% | -220.5% | ||
| Q3 24 | 8.4% | 5.4% | ||
| Q2 24 | 9.9% | 7.0% |
| Q1 26 | $0.05 | $0.63 | ||
| Q4 25 | $-12.98 | $0.67 | ||
| Q3 25 | $0.40 | $0.12 | ||
| Q2 25 | $0.33 | $0.11 | ||
| Q1 25 | $0.09 | $0.23 | ||
| Q4 24 | $0.36 | $-0.01 | ||
| Q3 24 | $0.74 | $0.06 | ||
| Q2 24 | $0.85 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $1.3M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $3.3B |
| Total Assets | $5.5B | $10.3B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $1.3M | ||
| Q4 25 | $133.2M | $1.2M | ||
| Q3 25 | $118.7M | $1.2M | ||
| Q2 25 | $131.4M | $1.5M | ||
| Q1 25 | $91.2M | $1.3M | ||
| Q4 24 | $76.3M | $1.3M | ||
| Q3 24 | $82.1M | $2.3M | ||
| Q2 24 | $77.2M | $2.8M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $5.8B | ||
| Q3 25 | $2.3B | $5.8B | ||
| Q2 25 | $2.3B | $5.8B | ||
| Q1 25 | $2.2B | $5.8B | ||
| Q4 24 | $2.0B | $5.8B | ||
| Q3 24 | $1.9B | $5.9B | ||
| Q2 24 | $1.8B | $5.8B |
| Q1 26 | $2.0B | $3.3B | ||
| Q4 25 | $1.9B | $3.3B | ||
| Q3 25 | $3.1B | $3.3B | ||
| Q2 25 | $3.1B | $3.3B | ||
| Q1 25 | $3.0B | $3.3B | ||
| Q4 24 | $3.1B | $3.4B | ||
| Q3 24 | $3.0B | $3.5B | ||
| Q2 24 | $3.0B | $3.7B |
| Q1 26 | $5.5B | $10.3B | ||
| Q4 25 | $5.5B | $10.6B | ||
| Q3 25 | $6.4B | $10.6B | ||
| Q2 25 | $6.3B | $10.6B | ||
| Q1 25 | $6.1B | $10.7B | ||
| Q4 24 | $6.0B | $10.9B | ||
| Q3 24 | $5.9B | $11.1B | ||
| Q2 24 | $5.7B | $11.1B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 1.77× | ||
| Q3 25 | 0.74× | 1.78× | ||
| Q2 25 | 0.74× | 1.74× | ||
| Q1 25 | 0.72× | 1.74× | ||
| Q4 24 | 0.64× | 1.69× | ||
| Q3 24 | 0.62× | 1.67× | ||
| Q2 24 | 0.62× | 1.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 4.9% |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $902.9M | ||
| Q3 25 | $73.2M | $234.9M | ||
| Q2 25 | $133.5M | $250.3M | ||
| Q1 25 | $11.5M | $156.2M | ||
| Q4 24 | $116.7M | $876.8M | ||
| Q3 24 | $163.1M | $230.3M | ||
| Q2 24 | $171.1M | $238.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $650.0M | ||
| Q3 25 | $-63.0M | $164.6M | ||
| Q2 25 | $-34.2M | $190.1M | ||
| Q1 25 | $-163.2M | $103.2M | ||
| Q4 24 | $-86.8M | $627.0M | ||
| Q3 24 | $-27.1M | $161.3M | ||
| Q2 24 | $16.9M | $171.1M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 150.1% | ||
| Q3 25 | -7.4% | 38.1% | ||
| Q2 25 | -3.9% | 44.7% | ||
| Q1 25 | -21.2% | 24.5% | ||
| Q4 24 | -11.2% | 148.3% | ||
| Q3 24 | -3.3% | 38.4% | ||
| Q2 24 | 2.1% | 41.2% |
| Q1 26 | — | 4.9% | ||
| Q4 25 | 11.3% | 58.4% | ||
| Q3 25 | 16.0% | 16.3% | ||
| Q2 25 | 19.3% | 14.2% | ||
| Q1 25 | 22.7% | 12.6% | ||
| Q4 24 | 26.3% | 59.1% | ||
| Q3 24 | 23.3% | 16.4% | ||
| Q2 24 | 19.4% | 16.2% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 4.05× | ||
| Q3 25 | 2.02× | 5.81× | ||
| Q2 25 | 4.43× | 6.64× | ||
| Q1 25 | 1.37× | 2.04× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 10.19× | ||
| Q2 24 | 2.18× | 8.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
UDR
| Rental income | $423.3M | 99% |
| Joint venture management and other fees | $2.5M | 1% |